The biology of TRAIL and the role of TRAIL-based therapeutics in infectious diseases

Brett D. Shepard, Andrew David Badley

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

TNF-related apoptosis inducing ligand (TRAIL) is a key mediator of the innate immune response to infection. While TRAIL-mediated apoptosis plays an essential role in the clearance of virus-infected cells, its physiologic role also includes immunosurveilance for cancer cells. Therapeutics that induce TRAIL-mediated apoptosis in cancer cells remain a focus of ongoing investigation in clinical trials, and much has been learned from these studies regarding the efficacy and toxicity of these interventions. These data, combined with data from numerous preclinical studies that detail the important and multifaceted role of TRAIL during infection with human immunodeficiency virus and other viruses, suggest that therapeutic exploitation of TRAIL signaling offers a novel and efficacious strategy for the management of infectious diseases.

Original languageEnglish (US)
Pages (from-to)87-101
Number of pages15
JournalAnti-Infective Agents in Medicinal Chemistry
Volume8
Issue number2
DOIs
StatePublished - 2009

Fingerprint

TNF-Related Apoptosis-Inducing Ligand
Communicable Diseases
Apoptosis
Viruses
Therapeutics
Infection
Innate Immunity
Neoplasms
Clinical Trials
HIV

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology

Cite this

The biology of TRAIL and the role of TRAIL-based therapeutics in infectious diseases. / Shepard, Brett D.; Badley, Andrew David.

In: Anti-Infective Agents in Medicinal Chemistry, Vol. 8, No. 2, 2009, p. 87-101.

Research output: Contribution to journalArticle

@article{9de5d229ee40444aaeda2a1814a678da,
title = "The biology of TRAIL and the role of TRAIL-based therapeutics in infectious diseases",
abstract = "TNF-related apoptosis inducing ligand (TRAIL) is a key mediator of the innate immune response to infection. While TRAIL-mediated apoptosis plays an essential role in the clearance of virus-infected cells, its physiologic role also includes immunosurveilance for cancer cells. Therapeutics that induce TRAIL-mediated apoptosis in cancer cells remain a focus of ongoing investigation in clinical trials, and much has been learned from these studies regarding the efficacy and toxicity of these interventions. These data, combined with data from numerous preclinical studies that detail the important and multifaceted role of TRAIL during infection with human immunodeficiency virus and other viruses, suggest that therapeutic exploitation of TRAIL signaling offers a novel and efficacious strategy for the management of infectious diseases.",
author = "Shepard, {Brett D.} and Badley, {Andrew David}",
year = "2009",
doi = "10.2174/187152109787846060",
language = "English (US)",
volume = "8",
pages = "87--101",
journal = "Anti-Infective Agents",
issn = "2211-3525",
publisher = "Bentham Science Publishers",
number = "2",

}

TY - JOUR

T1 - The biology of TRAIL and the role of TRAIL-based therapeutics in infectious diseases

AU - Shepard, Brett D.

AU - Badley, Andrew David

PY - 2009

Y1 - 2009

N2 - TNF-related apoptosis inducing ligand (TRAIL) is a key mediator of the innate immune response to infection. While TRAIL-mediated apoptosis plays an essential role in the clearance of virus-infected cells, its physiologic role also includes immunosurveilance for cancer cells. Therapeutics that induce TRAIL-mediated apoptosis in cancer cells remain a focus of ongoing investigation in clinical trials, and much has been learned from these studies regarding the efficacy and toxicity of these interventions. These data, combined with data from numerous preclinical studies that detail the important and multifaceted role of TRAIL during infection with human immunodeficiency virus and other viruses, suggest that therapeutic exploitation of TRAIL signaling offers a novel and efficacious strategy for the management of infectious diseases.

AB - TNF-related apoptosis inducing ligand (TRAIL) is a key mediator of the innate immune response to infection. While TRAIL-mediated apoptosis plays an essential role in the clearance of virus-infected cells, its physiologic role also includes immunosurveilance for cancer cells. Therapeutics that induce TRAIL-mediated apoptosis in cancer cells remain a focus of ongoing investigation in clinical trials, and much has been learned from these studies regarding the efficacy and toxicity of these interventions. These data, combined with data from numerous preclinical studies that detail the important and multifaceted role of TRAIL during infection with human immunodeficiency virus and other viruses, suggest that therapeutic exploitation of TRAIL signaling offers a novel and efficacious strategy for the management of infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=67651099147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651099147&partnerID=8YFLogxK

U2 - 10.2174/187152109787846060

DO - 10.2174/187152109787846060

M3 - Article

AN - SCOPUS:67651099147

VL - 8

SP - 87

EP - 101

JO - Anti-Infective Agents

JF - Anti-Infective Agents

SN - 2211-3525

IS - 2

ER -